CRCM LP

Q3 2026 13F-HR Holdings

Location
San Francisco, CA
Holdings as of
9/30/2026
Date filed
11/10/2026
Form type
13F-HR
Num holdings
19
Total value ($000)
$180,219
Net value change ($000)
+28,275 (18.6%)
New positions
8
Sold out positions
4
Turnover %
15.0%
Sector allocation + QoQ delta (equities-only)
Prev filing: 8/18/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
IAU 18,116 18.3%
ANAB 9,103 NEW
BTGO 2,913 42.9%
BNR 2,807 158.2%
APNIMED INC 2,576 NEW
IBIT 1,635 16.2%
VZLA 806 28.8%
NXE 657 NEW
PYPL 598 NEW
MSLE 579 NEW
Top Reduces (Value $000, Stocks/ETFs)
RNA -8,629 -100.0%
PCAP -1,652 -100.0%
ALTS -1,286 -17.3%
PLBY -1,123 -16.0%
PCSC -1,058 -100.0%
FIRST TRACKS BIOTHERAPEUTICS -711 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 1,690 (0.9% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type